ConductScience.org, home

Paper38245646

Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation.

Xiao X and 8 others. Ann Surg Oncol, 2024. Cited by 15 papers, by iCite.

Cite this record

ConductScience Library. Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation. Papers, record 38245646. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38245646

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of Skeletal Muscle Loss and Sarcopenia on Outcomes of Locally Advanced Esophageal Cancer during Neoadjuvant Chemoradiation.
PubMed
Journal
Ann Surg Oncol
PubMed
Year
2024
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
15
iCite
Relative citation ratio, by iCite
3.21, provisional
iCite
Revised in PubMed
2024-05-08
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xiao XXin
2Fang PHPin-Hao
3Zhou JFJian-Feng
4Li XKXiao-Kun
5Shang QXQi-Xin
6Yang YSYu-Shang
7Luan SYSi-Yuan
8Chen LQLong-Qi
9Yuan YYong

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
SarcopeniaMajor topic
Esophageal NeoplasmsMajor topic
Neoadjuvant TherapyMajor topic
Muscle, SkeletalMajor topic
EsophagectomyMajor topic
Humans
Male
Female
Retrospective Studies
Middle Aged
Survival Rate
Prognosis
Aged
Follow-Up Studies
Chemoradiotherapy
Postoperative Complications
Chemoradiotherapy, Adjuvant

Source PubMed

Download CSV of topics

Grants4

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
2022YFS0048Sichuan Science and Technology ProgramPubMed
81970481National Natural Science Foundation of ChinaPubMed
2020HXFH0471.3.5 project for disciplines of excellence, West China Hospital, Sichuan UniversityPubMed
20HXJS0051.3.5 project for disciplines of excellence, West China Hospital, Sichuan UniversityPubMed

Source PubMed

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135074509The development and progress of nanomedicine for esophageal cancer diagnosis and treatment.Semin Cancer Biol2022https://conductscience.org/library/papers/35074509PubMed
231319389Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw2019https://conductscience.org/library/papers/31319389PubMed
333423121The Impact of Pretherapeutic Naples Prognostic Score on Survival in Patients with Locally Advanced Esophageal Cancer.Ann Surg Oncol2021https://conductscience.org/library/papers/33423121PubMed
426416715Prognostic Significance of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Oncologic Outcomes of Esophageal Cancer: A Systematic Review and Meta-analysis.Ann Surg Oncol2016https://conductscience.org/library/papers/26416715PubMed
534664431Computed tomography-defined low skeletal muscle index and density in cancer patients: observations from a systematic review.J Cachexia Sarcopenia Muscle2021https://conductscience.org/library/papers/34664431PubMed
635794004Sarcopenia Determined by Skeletal Muscle Index Predicts Overall Survival, Disease-free Survival, and Postoperative Complications in Resectable Esophageal Cancer: A Systematic Review and Meta-analysis.Ann Surg2022https://conductscience.org/library/papers/35794004PubMed
733876359Quantity and Quality of Skeletal Muscle as an Important Predictor of Clinical Outcomes in Patients with Esophageal Cancer Undergoing Esophagectomy after Neoadjuvant Chemotherapy.Ann Surg Oncol2021https://conductscience.org/library/papers/33876359PubMed
828796017Sarcopenia: Prevalence, and Impact on Operative and Oncologic Outcomes in the Multimodal Management of Locally Advanced Esophageal Cancer.Ann Surg2017https://conductscience.org/library/papers/28796017PubMed
928437312Assessment of Sarcopenia as a Predictor of Poor Outcomes After Esophagectomy in Elderly Patients With Esophageal Cancer.Ann Surg2018https://conductscience.org/library/papers/28437312PubMed
1029488065Neoadjuvant Chemoradiotherapy for Patients with cT3/Nearly T4 Esophageal Cancer: Is Sarcopenia Correlated with Postoperative Complications and Prognosis?World J Surg2018https://conductscience.org/library/papers/29488065PubMed
1128024944Impact of sarcopenia on outcome in patients with esophageal resection following neoadjuvant chemotherapy for esophageal cancer.Eur J Surg Oncol2017https://conductscience.org/library/papers/28024944PubMed
1232014971Association Between Sarcopenia and Clinical Outcomes in Patients With Esophageal Cancer Under Neoadjuvant Therapy.Anticancer Res2020https://conductscience.org/library/papers/32014971PubMed
1325893413Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery.Ann Surg Oncol2015https://conductscience.org/library/papers/25893413PubMed
1431309328Association of skeletal muscle loss with the long-term outcomes of esophageal cancer patients treated with neoadjuvant chemotherapy.Surg Today2019https://conductscience.org/library/papers/31309328PubMed
1529433514Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study.World J Surg Oncol2018https://conductscience.org/library/papers/29433514PubMed
1628861809Negative Impact of Skeletal Muscle Wasting After Neoadjuvant Chemotherapy Followed by Surgery on Survival for Patients with Thoracic Esophageal Cancer.Ann Surg Oncol2017https://conductscience.org/library/papers/28861809PubMed
1727920002Decreased Skeletal Muscle Mass After Neoadjuvant Therapy Correlates with Poor Prognosis in Patients with Esophageal Cancer.Anticancer Res2016https://conductscience.org/library/papers/27920002PubMed
1818539529Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study.Lancet Oncol2008https://conductscience.org/library/papers/18539529PubMed
1918923576A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care.Appl Physiol Nutr Metab2008https://conductscience.org/library/papers/18923576PubMed
2015273542Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey.Ann Surg2004https://conductscience.org/library/papers/15273542PubMed

See all 35 referencesDownload CSV of references

Cited by9

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 15 citations.

PMIDTitleJournalYearIn PapersSource
42581617Prediction of Overall Survival in Patients With Oesophageal Cancer Using AI-Based 3D CT Body Composition Analysis.J Cachexia Sarcopenia Muscle2026https://conductscience.org/library/papers/42581617PubMed
42251209Prognostic Significance of the T12-SMI Before and After Neoadjuvant Chemoimmunotherapy for Esophageal Squamous Cell Carcinoma.Ann Surg Oncol2026https://conductscience.org/library/papers/42251209PubMed
42169887Sarcopenia in esophageal cancer: from passive prognostic marker to active treatment target.J Gastrointest Oncol2026https://conductscience.org/library/papers/42169887PubMed
41816377Assessing the prognostic impact of body composition phenotypes on surgical outcomes in patients with acute type A aortic dissection.J Thorac Dis2026https://conductscience.org/library/papers/41816377PubMed
41521251Sarcopenia, myosteatosis and systemic immunoinflammatory index in the prediction of survival in patients undergoing immunotherapy for esophageal cancer.Sci Rep2026https://conductscience.org/library/papers/41521251PubMed
41019539Impact of skeletal muscle loss and sarcopenia on outcomes of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma.Front Nutr2025https://conductscience.org/library/papers/41019539PubMed
40760116Body components at T12/L3 on CT and correlation with survival in esophageal cancer.Eur Radiol2026https://conductscience.org/library/papers/40760116PubMed
40607020Machine learning and the nomogram as the accurate tools for predicting postoperative malnutrition risk in esophageal cancer patients.Front Nutr2025https://conductscience.org/library/papers/40607020PubMed
40400988Computed tomography-based body composition and systemic inflammation for outcome prediction in patients with resectable esophageal squamous cell carcinoma.J Thorac Dis2025https://conductscience.org/library/papers/40400988PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38245646

GET https://conductscience.org/api/papers/v1/38245646/references?page=2